Status:

COMPLETED

Syncope: Pacing or Recording in the Later Years

Lead Sponsor:

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsors:

Vanderbilt University

Conditions:

Syncope

Heart Block

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Syncope affects about 50% of Canadians, is the cause of 1 - 2% of all emergency room visits, and probably is responsible for CDN $250 million in health care spending each year. It is associated with d...

Detailed Description

There are two general approaches to the patient with syncope and bifascicular block, a common substrate for intermittent heart block. The first is to assume that intermittent heart block is the cause,...

Eligibility Criteria

Inclusion

  • Patients are eligible if they have:
  • \>1 syncopal spell within 1 year preceding enrollment, and
  • bifascicular block on a 12-lead ECG, and
  • Age \> 50 years and
  • written informed consent. Syncope will be defined based on history using a standardized form.

Exclusion

  • Patients will be excluded if they have criteria related to study strategies, including:
  • previous pacemaker, ICD, or Implantable Loop Recorder in situ,
  • ACC/AHA/HRS Class I indication for permanent pacing or ICD implantation,
  • left ventricular ejection fraction \< 35% mandating ICD therapy,
  • contra-indication to a transvenous pacemaker such as artificial tricuspid valve or active sepsis.
  • Patients will also be excluded if a potential competing cause of syncope poses a threat to life, such as:
  • hypertrophic cardiomyopathy,
  • documented sustained ventricular tachycardia or
  • inducible, sustained monomorphic ventricular tachycardia on EP study.
  • They will be excluded if they have:
  • a history of myocardial infarction within 3 months prior to enrollment, and
  • a major chronic co-morbid medical condition that would preclude 24 months of follow-up.

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2017

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT01423994

Start Date

August 1 2011

End Date

November 1 2017

Last Update

May 16 2019

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Vanderbilt University

Nashville, Tennessee, United States, 37232

2

University of Calgary

Calgary, Alberta, Canada, T2N 4Z6

3

Royal Alexandra Hospital

Edmonton, Alberta, Canada, T6G 1K8

4

Victoria Heart Institute

Victoria, British Columbia, Canada, V8R 4R2